Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences Inks Contract with Janssen

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomarker services company Proteome Sciences said today that it will analyze samples and perform other services for Janssen Pharmaceutica, a Johnson & Jonson company that specializes in developing drugs for mental health conditions.

Under the contract with Janssen, Proteome Sciences will combine its TMT isobaric mass tag technology, sample preparation, and bioinformatics with mass spectrometry services using Thermo Fisher Scientific's Orbitrap Velos.

Proteome Sciences' biomarker offerings include gel-based and gel-free proteomics tools and rapid assays to measure and test differential protein expression, as well as identifying and quantitating proprietary proteins in cells, body fluids, and tissues.

Financial terms of the agreement were not released.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.